The global contrast agents market is expected to exceed US$ 5.65 billion by 2022, registering a compound annual growth rate (CAGR) of more than 4% during the forecast period. A large number of approvals for contrast agents and increasing number of public and private diagnostic centers are expected to drive the market. However, side effects and allergic reactions associated with contrast agents is hampering the growth of the market.
In this report, the global contrast agents market is segmented by product, route of administration, medical procedure, indication, application, and region. On the basis of product, the market is segmented into gadolinium-based contrast media, iodinated contrast media, high-osmolar contrast media, low-osmolar contrast media, and barium-based contrast media. The market by route of administration includes urethral, oral, rectal, and injection. The injection segment is further divided into intra-arterial and intravenous. On the basis of medical procedure, the market is segmented into catheterization laboratory, ultrasound, x-ray, computed tomography, and magnetic resonance imaging. The market on the basis of indication is segmented into oncology, neurological disorders, cardiovascular disorders, nephrological disorders, gastrointestinal disorders, and musculoskeletal anomalies. On the basis of application, the market is segmented into radiology, interventional cardiology, and interventional radiology.
The global contrast agents market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional contrast agents market and analyzes the variations in the growth of the industry in certain regions.
Bayer Healthcare Pharmaceuticals, Medrad Inc., SupertechInc, Lantheus Medical, ACIST Medical Systems, AMAG Pharmaceuticals, Inc, Canadian Imaging, NanoScan Imaging, Pinyons Medical Technology, TargesonInc, Beekley Medical, Mallinckrodt Pharmaceuticals, Nova Biomedical, NycomedAmersham, Daiichi, Covidien, GE Healthcare, Bracco Diagnostic Inc., and Guerbet Group are the most active players in the contrast agents market.
A glimpse of the report structure is provided in the report description available on the website.
This report covers the contrast agents market, in terms of value, and forecasts the market size till 2022. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.
The deep-dive study on the contrast agents market will help customers with the identification of new market opportunities and targeted promotional plans.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
Information contained on this page is provided by an independent third-party content provider. Frankly and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact firstname.lastname@example.org